Nano Biotechnology

Nanobiotechnology is a science that develops and applies nanotechnology tools to the study of biological phenomena. Nanoparticles, for example, may act as probes, sensors or biomolecule delivery vehicles in cellular systems.

The research that is improved by nanobiology include: nanodevices (such as biological machines), nanoparticles, and nanoscale phenomena that exist within the nanotechnology discipline. This technical approach to biology enables scientists to visualize and construct structures that can be used for biological research.

Bionanotechnology applications are extremely widespread. As far as the distinction is concerned, nanobiotechnology is much more common in that it simply provides more tools for the study of biology. Bionanotechnology, on the other hand, promises to recreate biological mechanisms and pathways in a way that is useful in other ways.

This field relies on a variety of research methods, including imaging, characterization via AFM/optical tweezers, x-ray diffraction based tools, self-assembly synthesis, self-assembly characterization such as MP-SPR, DPI, recombinant DNA methods, theory (e.g. statistical mechanics, nanomechanics, etc.) and computational approaches (bottom-up multi-scale simulation, supercomputing).

The U.S. market is estimated at $18.4 billion, while China is forecast to grow at 6.6 per cent of CAGR.

The market for nanobiotechnology in the United States is estimated at US$18.4 billion in 2020. China, the second largest economy in the world, is projected to reach an estimated market size of US$17.6 billion by 2027, following a CAGR of 6.6 per cent over the 2020-2027 analysis period. Among the other significant geographic markets, Japan and Canada are projected to grow at 6.7% and 5.7% respectively over the 2020-2027 period. Germany is projected to grow to around 5.7% of CAGR in Europe.